Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning

Sponsor
University of Aarhus (Other)
Overall Status
Completed
CT.gov ID
NCT02898480
Collaborator
(none)
20
1
8

Study Details

Study Description

Brief Summary

Remote ischemic conditioning (RIC) is a therapeutic strategy for protecting organs or tissue against the detrimental effects of acute ischemia-reperfusion injury. It remains unknown whether this can be used in retinal vascular occlusive diseases. The purpose of the present study is to examine whether the autoregulation of retinal vessel diameters in normal persons change after remote ischemic conditioning.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Remote ischemic conditioning
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning
Study Start Date :
Sep 1, 2016
Actual Primary Completion Date :
Nov 14, 2016
Actual Study Completion Date :
May 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Remote ischemic conditioning

Procedure: Remote ischemic conditioning
Briefly reversible restricting of blood flow to upper limb in four cycles of 5 minutes of inflation at 200mm Hg followed by 5 minutes of deflation.

Outcome Measures

Primary Outcome Measures

  1. Diameter change of retinal vessel [immediate]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Normal persons
Exclusion Criteria:
  • Present or previous eye disease

  • Use of medications except anti-conceptive

  • Epilepsy

  • Pregnancy or lactation

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Aarhus

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT02898480
Other Study ID Numbers:
  • RIK-DVA
First Posted:
Sep 13, 2016
Last Update Posted:
Apr 5, 2019
Last Verified:
Nov 1, 2017
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2019